Skip to: Content
Skip to: Site Navigation
Skip to: Search

August 21, 2008 4:45:21 PM CDT

Learn about Newser Points »

Stories related to: diabetes

Stories

Stories 41 - 51 of 51

<< Prev 1 2 3
  • August 2007

    • Bone Hormone Could Help Treat Diabetes

      Boston Globe  |  Aug 13, 07 3:08 PM CDT

      Bone Hormone Could Help Treat Diabetes

      (Newser) - A substance produced by the skeleton may help to treat diabetes, a new study suggests. A hormone called osteocalcin regulates blood sugar; type 2 diabetics have a lower level of the hormone than other people. In the study, mice with lower levels of osteocalcin develop symptoms of diabetes, which go away when they are injected with the hormone. More »

      Tags

      health  • diabetes  • hormones  • treatment  • blood sugar  • skeleton  • bones  • osteocalcin

  • July 2007
  • June 2007

    • Coffee's Perks Not in the Caffeine

      Los Angeles Times  |  Jun 25, 07 3:59 AM CDT

      Coffee's Perks Not in the Caffeine

      (Newser) - Scientists have long championed coffee's health benefits, but a series of recent studies is waking them up to the fact that caffeine has nothing to do with it. Regular consumption of coffee or tea can provide protection against cancer, diabetes and heart disease, but researchers say other chemicals are responsible. More »

      Tags

      health  • cancer  • science  • heart disease  • diabetes  • coffee  • stress  • caffeine  • tea  • antioxidants

    • Genes Give Up Secrets of 7 Serious Diseases

      BBC  |  Jun 7, 07 8:18 AM CDT

      Genes Give Up Secrets of 7 Serious Diseases

      (Newser) - In an outcome one scientist describes as a "new dawn," researchers have identified genetic variations linked to seven common diseases, opening the door to improved tests and treatments. The study, which focused on depression, Crohn's disease, coronary artery disease, hypertension, rheumatoid arthritis, and Type 1 and 2 diabetes, also found unexpected links between some of the ailments. More »

      Tags

      health  • medicine  • heart disease  • disease  • genetics  • depression  • diabetes  • hypertension  • rheumatoid arthritis  • Crohn's disease

    • Controversy Rages Over Diabetes Drug's Heart Risks

      New York Times  |  Jun 6, 07 12:16 PM CDT

      Controversy Rages Over Diabetes Drug's Heart Risks

      (Newser) - Troubling questions about the diabetes drug Avandia persisted yesterday as an FDA official revealed that she was barred from recommending a critical warning about the medication, the Times reports. In the run-up to congressional hearings that began today, manufacturer GlaxoSmithKline rushed to disseminate interim clinical findings in hopes of blunting the controversy. More »

      Tags

      health  • medicine  • FDA  • diabetes  • heart attack  • heart  • GlaxoSmithKline  • Avandia

  • May 2007

    • Glaxo Stems Stock Slide Over Avandia

      Daily Telegraph (UK)  |  May 31, 07 6:44 AM CDT

      Glaxo Stems Stock Slide Over Avandia

      (Newser) - Glaxo shares pulled out of a tailspin after the pharma giant defended its second biggest selling drug, Avandia, against claims that it triggers heart attacks.  A sharply worded letter from the company's chief medical officer on the website of medical journal The Lancet pointed out that the increased incidence of heart attacks among Avandia patients—0.6%—was still very small. More »

      Tags

      drugs  • medicine  • diabetes  • heart attack  • GlaxoSmithKline  • Avandia  • pharma

    • FDA Warned of Avandia Risks Years Ago

      New York Times  |  May 24, 07 1:56 PM CDT

      FDA Warned of Avandia Risks Years Ago

      (Newser) - A diabetes doctor warned the FDA of heart risks posed by the diabetes drug Avandia seven years ago, the New York Times reports. The same concerns raised by Dr. John Buse in a 2000 letter were reiterated in a study published by cardiologist Steven Nissen this week. More »

      Tags

      health  • diabetes  • GlaxoSmithKline  • Avandia  • pharma

    • Drug Company Nemesis Strikes Again

      Wall Street Journal  |  May 22, 07 1:32 PM CDT

      Drug Company Nemesis Strikes Again

      (Newser) - The doctor who helped to raise concerns about the painkiller Vioxx is back—with the study released earlier this week linking the same company's popular diabetes drug, Avandia, to higher risk of heart attacks. The Wall Street Journal looks at 58-year-old cardiologist Steven Nissen's role in identifying and publicizing drug risks. More »

      Tags

      drugs  • medicine  • FDA  • diabetes  • pharmaceutical companies  • GlaxoSmithKline  • Avandia  • Vioxx

    • Diabetes Drug Ups Heart Risk

      Associated Press  |  May 21, 07 3:15 PM CDT

      Diabetes Drug Ups Heart Risk

      (Newser) - A popular diabetes drug may increase heart attack risks, a study reported in the New England Journal of Medicine concludes. Patients who took Avandia, which treats Type 2 diabetes, were 43% more likely to have a heart attack than those who took a placebo, the Cleveland Clinic study found. More »

      Tags

      health  • medicine  • FDA  • medical research  • diabetes  • heart attack  • pharmaceutical companies  • GlaxoSmithKline  • Avandia  • pharma

  • April 2007

Stories 41 - 51 of 51

<< Prev 1 2 3

Today's Most Popular

Premium Articles from HighBeam

Find more articles like this

What is Newser?

2008 Codie Finalist

Newser gives you more news in less time. We search for the best and most important stories all over the web, read them for you, and deliver concise and sharp summaries—along with links to the full text. Newser provides a way to stay on top of an ever-expanding horizon of news and opinion—politics, sports, business, trends, technology, personalities, crimes, and controversies. Newser keeps you not just better informed, but, with our signature graphic interface and smart condensed format, more enjoyably informed.

Learn more »